Blood cancer drug success

A life-saving blood cancer drug, trialled in Ireland, is now available to patients with limited treatment options.

The once-daily oral treatment, containing the active substance ibrutinib, has been shown to prolong survival for patients with three types of blood cancer.

The complex and rare diseases are chronic lymphocytic leukaemia, mantle cell lymphoma and Waldenstrom’s macroglobulinemia.